Course Overview
Explore cardiovascular implications for oncology patients and key prevention and mitigation strategies in this non-CE course. You’ll examine the lingering effects of anti-cancer treatment on the cardiovascular system and the longevity of patients’ life span after cancer treatment, including in childhood survivors. We’ll unearth the power of team-based care through a compelling patient case study that navigates transitions of care throughout cancer treatment and ongoing cardiovascular management.
This course was part of the 2023 Cardio-Connections Summit. You can read the summary and find the recordings here.
Member Cost: $0Non-member Cost: $0
Credits: 0.0 CE contact hours, 0.0 CE pharmacology hours
Learning Objectives
- Review the cardiovascular implications for oncology patients, including the cardio-toxicity of anti-cancer treatments and prevention/mitigation strategies.
- Examine the lingering effects of anti-cancer treatment on the cardiovascular system and the implications of childhood cancers or longevity of patients' life span after cancer treatment.
- Discuss the importance of Team-based Care with a patient case study highlighting transitions of care through cancer treatment and ongoing cardiovascular disease management.
A non-CE certificate of attendance/participation is available upon submission of the program evaluation.
Faculty
- Anecita Fadol, PhD, APRN, FAANP, FAAN
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.